SYRE - Latest News

Spyre Therapeutics, Inc. (SYRE), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $4.61B. Beta to the broader market is 3.13.

The article list below shows the most recent SYRE headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent SYRE Headlines

Spyre Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

globenewswire.com - May 5, 2026

Announced positive topline induction data from Part A of the Phase 2 SKYLINE trial of SPY001, demonstrating best-in-class efficacy potential and a saf

Spyre Therapeutics Announces Grants of Inducement Awards

globenewswire.com - May 1, 2026

WALTHAM, Mass. , May 01, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc.

SYRE Stock Jumps More Than 70% in a Month: What Is Driving This Rally?

zacks.com - Apr 23, 2026

Spyre Therapeutics' stock rises 73% in a month after mid-stage data show strong efficacy and safety for SPY001 in ulcerative colitis, boosting investo

Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million

globenewswire.com - Apr 16, 2026

WALTHAM, Mass. , April 16, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc.

Spyre Therapeutics (NASDAQ:SYRE) Shares Gap Up Following Analyst Upgrade

defenseworld.net - Apr 15, 2026

Spyre Therapeutics, Inc. (NASDAQ: SYRE - Get Free Report)'s share price gapped up before the market opened on Tuesday after Robert W.

How News Affects SYRE Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track SYRE's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked SYRE news questions

What is the latest SYRE news headline?

The most recent SYRE headline (May 5, 2026) is "Spyre Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the SYRE news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What SYRE news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual SYRE options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.